On September 26, 2023, Nexus Pharmaceuticals, LLC[1] announced[2] that it had received approval from the U.S. Food and Drug Administration (FDA) for Fluorescein Injection, USP. Nexus Pharmaceuticals ...
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC announced it has received U.S. Food and Drug Administration (FDA) approval for Fluorescein Injection, USP. “Receiving FDA approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results